Zacks Market Edge Highlights: Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties and AbbVie

For Immediate Release

Chicago, IL – March 15, 2018 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/295632/the-best-marijuana-stocks-right-now)

The Best Marijuana Stocks Right Now

Welcome to Episode #123 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

In this episode, Tracey is joined by David Bartosiak, the Editor of Zacks Surprise Trader, Momentum Trader and Blockchain Innovators newsletters, to discuss one of their favorite topics: marijuana stocks.

On Jan 17, 2017, Tracey and Dave first explored the marijuana investment options in the podcast titled “Can You Get Rich Off Marijuana Stocks?”

Back in early 2017, the investment pickings were slim.

Have things changed in 2018?

Maturing of the Pot Stock Industry

Demand remains high for “pot stocks.” For that reason, several marijuana ETFs have now launched and more businesses are looking for ways to get a foothold in the industry.

In addition to the stocks they talked about last year, Tracey and Dave also found several more investing options.

They focused on those that are traded on the US exchanges and have, or soon will have, Zacks Rank. That means some stocks that trade on the Pink Sheets, like Aurora Cannabis (ACBFF) for example, are not high on their list even though it has a $4.4 billion market cap.

5 Stocks that get you into the Marijuana Trade

1.       The Scotts Miracle-Gro Company SMG making potting soil specifically for growing marijuana. While it was a stock mentioned on the 2017 podcast, its performance hasn’t been that great. Shares have fallen 2.3% in that time.

2.       GW Pharmaceuticals GWPH is a British biopharmaceutical company that is developing cannabis medicines. It’s lead product is in development to treat rare and catastrophic forms of childhood on-set epilepsy. It’s expected to lose $8.95 per share in fiscal 2018 and another $6.12 in fiscal 2019. Shares are up just 1% since the January 2017 podcast.

3.       Innovative Industrial Properties IIPR is a REIT that manages free-standing properties for growing licensed medical-use cannabis. These facilities are operated by state licensed growers. It has buildings in New York, Maryland, Minnesota and just acquired a site in Arizona which has a long-term lease. Earnings are expected to be $0.19 in 2017 and $1.32 in 2018. It has paid out a distribution in 2017. Shares are up 44% since the Jan 17, 2017 podcast.

4.       AbbVie ABBV is a large cap US biopharmaceutical company which just happens to be one of the first with an FDA approved cannabis-based drug, Marinol, on the market. Marinol is approved for chemotherapy induced nausea and vomiting and anorexia. AbbVie is expected to grow earnings by 33% in 2018 yet trades with a forward P/E of just 15.8.

5.       Cronos Group listed on the NASDAQ exchange on Feb 27, 2018. This Canadian based company cultivates medical marijuana companies and owns 100% of Peace Naturals, 100% of Original BC and 21.5% of Whistler Medical Marijuana Company. It doesn’t yet have a Zacks Rank. Stay tuned.

There are other biopharmaceuticals that are in the development stages of cannabis-based therapies and treatments. Additionally, some of the large food and beverage companies are looking for ways to invest in cannabis food and drink products.

What other stocks could be marijuana investments in 2018?

Listen to the podcast to find out.

Don’t Even Think About Buying Bitcoin Until You Read This

The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.

Zacks’ has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

Tracey Ryniec manages the Insider Trader and Value Investor portfolios at Zacks.com. She hosts 2 weekly podcasts: Zacks Market Edge Podcast and the Value Investor Podcast. You can also catch her on Twitter at @TraceyRyniec.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!  Click here for your free subscription to Profit from the Pros.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
GW Pharmaceuticals PLC (GWPH) : Free Stock Analysis Report
 
Scotts Miracle-Gro Company (The) (SMG) : Free Stock Analysis Report
 
Innovative Industrial Properties, Inc. (IIPR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research